The Biology of Plasmodium vivax
Open Access
- 10 May 2017
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Medicine
- Vol. 7 (9), a025585
- https://doi.org/10.1101/cshperspect.a025585
Abstract
Plasmodium vivax is the second most prevalent cause of malaria worldwide and the leading cause of malaria outside of Africa. Although infections are seldom fatal clinical disease can be debilitating and imposes significant health and economic impacts on affected populations. Estimates of transmission and prevalence intensity can be problematic because many episodes of vivax originate from hypnozoite stages in the liver that have remained dormant from previous infections by an unknown mechanism. Lack of treatment options to clear hypnozoites and the ability to infect mosquitoes before disease symptoms present represent major challenges for control and eradication of vivax malaria. Compounding these challenges is the unique biology of P. vivax and limited progress in development of experimental research tools, thereby hindering development of new drugs and vaccines. Renewed emphasis on vivax malaria research is beginning to make progress in overcoming some of these challenges.This publication has 100 references indexed in Scilit:
- Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivaxThe Journal of Infectious Diseases, 2013
- Comparative Ex Vivo Activity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivaxAntimicrobial Agents and Chemotherapy, 2012
- The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparumNature Genetics, 2012
- Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparumNature, 2011
- A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivaxBlood, 2011
- Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and EliminationClinical Microbiology Reviews, 2011
- In Vitro Activity of Pyronaridine against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivaxAntimicrobial Agents and Chemotherapy, 2010
- Mapping Epitopes of the Plasmodium vivax Duffy Binding Protein with Naturally Acquired Inhibitory AntibodiesInfection and Immunity, 2010
- Strain-Specific Duffy Binding Protein Antibodies Correlate with Protection against Infection with Homologous Compared to Heterologous Plasmodium vivax Strains in Papua New Guinean ChildrenInfection and Immunity, 2009
- Naturally acquired inhibitory antibodies toPlasmodium vivaxDuffy binding protein are short-lived and allele-specific following a single malaria infectionClinical and Experimental Immunology, 2009